Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

The objective of this case-control study was to compare the efficacy and toxicity of lenalidomide plus dexamethasone (len/dex) versus thalidomide plus dexamethasone (thal/dex) as initial therapy for newly diagnosed myeloma. We retrospectively studied 411 newly diagnosed patients treated with len/dex...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gay, Francesca, Hayman, Suzanne R., Lacy, Martha Q., Buadi, Francis, Gertz, Morie A., Kumar, Shaji, Dispenzieri, Angela, Mikhael, Joseph R., Bergsagel, P. Leif, Dingli, David, Reeder, Craig B., Lust, John A., Russell, Stephen J., Roy, Vivek, Zeldenrust, Steven R., Witzig, Thomas E., Fonseca, Rafael, Kyle, Robert A., Greipp, Philip R., Stewart, A. Keith, Rajkumar, S. Vincent
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826759/
https://ncbi.nlm.nih.gov/pubmed/20008302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-08-239046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados